These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 20138167

  • 1. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.
    Chen B, Yang D, Chen Y, Xu W, Ye B, Ni Z.
    Clin Chim Acta; 2010 May 02; 411(9-10):705-9. PubMed ID: 20138167
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K, Bayram F, Capak M, Tanriverdi F, Karaman A, Ozturk A, Altunbas H, Gökce C, Kalkan A, Yazici C.
    Metab Syndr Relat Disord; 2009 Oct 02; 7(5):427-34. PubMed ID: 19754305
    [Abstract] [Full Text] [Related]

  • 3. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD, Chiou WK, Weng HF, Fang JT, Liu TH.
    Clin Nutr; 2004 Dec 02; 23(6):1313-23. PubMed ID: 15556253
    [Abstract] [Full Text] [Related]

  • 4. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
    Lin CC, Liu CS, Li TC, Chen CC, Li CI, Lin WY.
    Eur J Clin Invest; 2007 Oct 02; 37(10):783-90. PubMed ID: 17888089
    [Abstract] [Full Text] [Related]

  • 5. [Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai].
    Li Q, Jia WP, Lu JQ, Chen L, Wu YM, Jiang SY, Xiang KS.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jan 02; 25(1):65-8. PubMed ID: 15061951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z, Xu X, Wu X, Zhou C, Li D.
    Asia Pac J Clin Nutr; 2009 Jan 02; 18(1):81-7. PubMed ID: 19329400
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevalence and predictors of microalbuminuria in persons with various glucose tolerance levels].
    Huo L, Xu M, Huang HE, Li R, Dai M, Wang JG, Ning G, Li XY.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2537-40. PubMed ID: 18067826
    [Abstract] [Full Text] [Related]

  • 11. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD Project.
    Gil K, Radziłłowicz P, Zdrojewski T, Pakalska-Korcala A, Chwojnicki K, Piwoński J, Ignaszewska-Wyrzykowska A, Załuga L, Mielczarek M, Landowski J, Wyrzykowski B.
    Kardiol Pol; 2006 May 25; 64(5):464-9. PubMed ID: 16752328
    [Abstract] [Full Text] [Related]

  • 12. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ, Ahn JM, Lee TW, Chin HJ, Na KY, Chae DW, Kim S.
    Hypertens Res; 2010 Jun 25; 33(6):573-8. PubMed ID: 20379188
    [Abstract] [Full Text] [Related]

  • 13. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95.
    Liese AD, Hense HW, Döring A, Stieber J, Keil U.
    J Hum Hypertens; 2001 Nov 25; 15(11):799-804. PubMed ID: 11687925
    [Abstract] [Full Text] [Related]

  • 14. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients.
    Lee JE, Huh W, Son HJ, Kim YG, Kim DJ, Lee MK, Oh HY.
    Nephron Clin Pract; 2007 Nov 25; 106(3):c98-103. PubMed ID: 17522477
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranhão TM.
    Fertil Steril; 2008 Mar 25; 89(3):649-55. PubMed ID: 17543961
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.
    Am J Hypertens; 2008 Jan 25; 21(1):17-22. PubMed ID: 18091739
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and characteristics of the metabolic syndrome among adults in Beijing, China.
    Li G, de Courten M, Jiao S, Wang Y.
    Asia Pac J Clin Nutr; 2010 Jan 25; 19(1):98-102. PubMed ID: 20199993
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.
    Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F, Giovannitti MG, Pucci L, Del Prato S.
    Nutr Metab Cardiovasc Dis; 2005 Aug 25; 15(4):250-4. PubMed ID: 16054548
    [Abstract] [Full Text] [Related]

  • 19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A, Temizhan A, Abaci A, Kozan O, Erol C, Ongen Z, Celik S.
    Anadolu Kardiyol Derg; 2008 Dec 25; 8(6):401-6. PubMed ID: 19103534
    [Abstract] [Full Text] [Related]

  • 20. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM, Wagner T, Marsalek P.
    J Hum Hypertens; 2004 Sep 25; 18(9):669-75. PubMed ID: 15269705
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.